Key facts
- It has raised $2.7M; the latest was Later Stage VC ($2.7M) in Dec 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Ai4Eyes
- ·The full record, as it builds
Funding rounds
No funding rounds for Ai4Eyes are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ai4Eyes
Developer of an artificial intelligence-enhanced medical device designed for dry eye disease treatment. The company specializes in a cloud-based artificial intelligence system that continuously improves its algorithm with feedback from a network of doctors, enabling doctors to treat patients with relevant treatment and enjoy portable and affordable subscription plans.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2020
- Website
- aiforeyes.com/
- Ownership
- Privately Held (backing)
Ai4Eyes doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ai4Eyes shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ai4Eyes in its N-PORT filings yet. We sweep new filings monthly.